TwinBeech Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,000
Closed -$1.45M 542
2025
Q4
$1.45M Buy
+18,000
New +$1.51M 0.1% 239
2025
Q2
Sell
-7,261
Closed -$361K 608
2025
Q1
$361K Buy
7,261
+3,417
+89% +$216K 0.01% 604
2024
Q4
$269K Buy
+3,844
New +$319K ﹤0.01% 523
2024
Q1
Sell
-72,397
Closed -$9.39M 524
2023
Q4
$9.39M Buy
72,397
+10,464
+17% +$1.44M 0.15% 183
2023
Q3
$10.1M Buy
+61,933
New +$10.9M 0.19% 148
2023
Q2
Sell
-39,814
Closed -$5.31M 566
2023
Q1
$5.31M Buy
+39,814
New +$4.68M 0.11% 231

Other funds holding ACLS

TwinBeech Capital's ACLS Position: Q1 2026 in Review

TwinBeech Capital sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 18,000 shares — an estimated $1.45M sold.

TwinBeech Capital first reported a position in ACLS in Q1 2023 and held it in 6 quarters. The position peaked at $10.1M in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • TwinBeech Capital reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • TwinBeech Capital sold 18,000 Axcelis shares in Q1 2026, an estimated $1.45M.
  • TwinBeech Capital first reported a position in Axcelis in Q1 2023 and held it in 6 quarters.
  • TwinBeech Capital's Axcelis position peaked at $10.1M in Q3 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.